Orthofix Medical (OFIX) Expected to Post Earnings on Monday

Orthofix Medical (NASDAQ:OFIX) is projected to post its Q3 2026 results before the market opens on Monday, November 9th. Analysts expect Orthofix Medical to post earnings of $0.11 per share and revenue of $210.52 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Monday, November 9, 2026 at 8:30 AM ET.

Orthofix Medical (NASDAQ:OFIX) last issued its quarterly earnings results on Wednesday, August 5th. The medical device company reported ($0.39) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.02. Orthofix Medical had a negative return on equity of 14.05% and a negative net margin of 7.41%. The firm had revenue of $210.93 million for the quarter, compared to analyst estimates of $209.28 million. On average, analysts expect Orthofix Medical to post ($1.29) EPS for the current fiscal year and ($1.07) EPS for the next fiscal year.

Orthofix Medical Stock Down 11.8%

Shares of OFIX opened at $7.87 on Friday. Orthofix Medical has a one year low of $7.81 and a one year high of $16.42. The stock has a market capitalization of $320.55 million, a price-to-earnings ratio of -5.11 and a beta of 0.66. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.67 and a current ratio of 2.84. The stock has a 50 day moving average price of $9.29 and a 200 day moving average price of $10.99.

Analysts Set New Price Targets

Several brokerages have recently weighed in on OFIX. Canaccord Genuity Group reduced their price objective on shares of Orthofix Medical from $18.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, August 10th. Weiss Ratings downgraded shares of Orthofix Medical from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $14.75.

Orthofix Medical Company Profile

Orthofix Medical Inc is a medical device company focused on spinal and orthopedic solutions. The company develops, manufactures and distributes products designed to help treat spinal disorders, support bone healing and address orthopedic trauma and related musculoskeletal conditions.

Its product portfolio includes spinal fixation and interbody systems, biologics and bone-grafting products, bone growth stimulation devices, and technologies for spinal motion preservation and deformity correction.